Menu
GeneBe

7-150742750-T-C

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_018384.5(GIMAP5):c.611T>C(p.Leu204Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00281 in 1,614,186 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 10 hom. )

Consequence

GIMAP5
NM_018384.5 missense

Scores

6
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4B:1

Conservation

PhyloP100: 3.20
Variant links:
Genes affected
GIMAP5 (HGNC:18005): (GTPase, IMAP family member 5) This gene encodes a protein belonging to the GTP-binding superfamily and to the immuno-associated nucleotide (IAN) subfamily of nucleotide-binding proteins. In humans, the IAN subfamily genes are located in a cluster at 7q36.1. This gene encodes an antiapoptotic protein that functions in T-cell survival. Polymorphisms in this gene are associated with systemic lupus erythematosus. Read-through transcription exists between this gene and the neighboring upstream GIMAP1 (GTPase, IMAP family member 1) gene. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019603252).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GIMAP5NM_018384.5 linkuse as main transcriptc.611T>C p.Leu204Pro missense_variant 3/3 ENST00000358647.5
GIMAP1-GIMAP5NM_001199577.2 linkuse as main transcriptc.1223T>C p.Leu408Pro missense_variant 6/6
GIMAP1-GIMAP5NM_001303630.2 linkuse as main transcriptc.839T>C p.Leu280Pro missense_variant 5/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GIMAP5ENST00000358647.5 linkuse as main transcriptc.611T>C p.Leu204Pro missense_variant 3/31 NM_018384.5 P1Q96F15-1

Frequencies

GnomAD3 genomes
AF:
0.00188
AC:
286
AN:
152182
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00160
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00317
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.00204
AC:
512
AN:
251010
Hom.:
1
AF XY:
0.00198
AC XY:
269
AN XY:
135678
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00294
Gnomad FIN exome
AF:
0.00166
Gnomad NFE exome
AF:
0.00291
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00291
AC:
4249
AN:
1461886
Hom.:
10
Cov.:
73
AF XY:
0.00298
AC XY:
2166
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.000448
Gnomad4 AMR exome
AF:
0.000961
Gnomad4 ASJ exome
AF:
0.000995
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00291
Gnomad4 FIN exome
AF:
0.00144
Gnomad4 NFE exome
AF:
0.00332
Gnomad4 OTH exome
AF:
0.00228
GnomAD4 genome
AF:
0.00188
AC:
286
AN:
152300
Hom.:
1
Cov.:
32
AF XY:
0.00180
AC XY:
134
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.000505
Gnomad4 AMR
AF:
0.00111
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00228
Gnomad4 FIN
AF:
0.00160
Gnomad4 NFE
AF:
0.00318
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.00243
Hom.:
1
Bravo
AF:
0.00161
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00361
AC:
31
ExAC
AF:
0.00207
AC:
251
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00333
EpiControl
AF:
0.00338

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Portal hypertension, noncirrhotic, 2 Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGMFeb 14, 2023The missense c.611T>C (p.Leu204Pro) in GIMAP5 gene has been reported previously in homozygous state in individuals affected with GIMAP5-associated hypertension (Patterson et al. 2018; Drzewiecki et al. 2021). Experimental studies demonstrated an undetectable protein expression of both GIMAP5 isoforms for this variant (Patterson et al. 2018). This variant is reported with an allele frequency of 0.2% in the gnomAD exomes database. This variant has been reported to the ClinVar database as Likely Pathogenic / Pathogenic. The amino acid change p.Leu204Pro in GIMAP5 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Leu at position 204 is changed to a Pro changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, no assertion criteria providedliterature onlyOMIMAug 02, 2021- -
Likely pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 04, 2024Variant summary: GIMAP5 c.611T>C (p.Leu204Pro) results in a non-conservative amino acid change located in the AIG1-type guanine nucleotide-binding (G) domain (IPR006703) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 251010 control chromosomes in the gnomAD database, including 1 homozygotes. c.611T>C has been reported in the literature in a homozygous individuals affected with GIMAP5-associated hypertension. T cells isolated from this patient had complete loss of GIMAP5 protein expression, reduced T cell proliferation which was restored upon pharmacological targeting of GSK3. (example: Patterson_2018, and Drewieck_GIMAP5_JEM_2021). These data indicate that the variant may be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 33956074, 29382851, 35753512).Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic/likely pathogenic (n=2) and likely benign (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Portal hypertension Pathogenic:1
Likely pathogenic, no assertion criteria providedliterature onlyYale Center for Mendelian Genomics, Yale UniversityMay 06, 2021- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2022GIMAP1-GIMAP5: BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
Cadd
Benign
22
Dann
Uncertain
1.0
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.58
T;.;T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.020
T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
0.98
D
PrimateAI
Benign
0.44
T
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
1.0
.;D;D
Vest4
0.48
MVP
0.54
MPC
0.19
ClinPred
0.066
T
GERP RS
3.1
Varity_R
0.82
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72650695; hg19: chr7-150439838; API